Can-Fite publishes study results on canine osteoarthritis drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/8/2026

1. SPCX
2. CRNX
3. USO
4. VRTX
5. RIVN
6. SPY
7. NVDA
8. LMT
9. WMT
10. CMPS

Go back to Can-Fite publishes study results on canine osteoarthritis drug
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.48 -0.32 (8.42%)
Previous Close $3.80    52 Week High $3.89 
Open $3.69    52 Week Low $1.85 
Day High $3.85    P/E N/A 
Day Low $3.41    EPS $0.00 
Volume 197,123       

(NASDAQ: CFBI) Delayed: 10.08 --0 (-0%)
Previous Close $10.08    52 Week High $ 
Open $41.64    52 Week Low $ 
Day High $10.08    P/E N/A 
Day Low $10.08    EPS $ 
Volume 206